EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells
- PMID: 12039842
- DOI: 10.1096/fj.01-0805fje
EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells
Abstract
Interaction between ephrinB2 and EphB4 in endothelial cells at the arterial-venous capillary interface is critical for proper embryonic capillary morphogenesis. However, the intracellular downstream signaling of ephrinB2-EphB in vascular endothelial cells is unknown. This study examined the effect of ephrinB2-induced activation of EphB kinases on vascular endothelial growth factor (VEGF)- and angiopoietin-1 (Ang1)-induced Ras/mitogen-activated protein kinase (MAPK) signaling cascades in human umbilical vein endothelial cells (HUVECs). Reverse transcriptase-polymer chain reaction results showed that HUVECs expressed three kinds of EphB kinases known to bind to ephrinB2: EphB2, EphB3, and EphB4. EphrinB2 not only increased the phosphorylation of EphB2 and EphB4 in a time-dependent manner but also increased recruitment of p120-Ras-GTPase-activating protein (p120-RasGAP) to EphB2 and EphB4. Accordingly, ephrinB2 inhibited VEGF- and Ang1-induced Ras-MAPK activities, whereas ephrinB2 did not alter VEGF-induced Flk phosphorylation or Ang1-induced Tie2 phosphorylation. Furthermore, ephrinB2 suppressed VEGF- and Ang1-induced proliferation and/or migration, which are mediated mainly through Ras/MAPK signaling cascades. From these results, we propose that ephrinB2-EphB, signaling through Ras/MAPK cascade, may be critical for proper morphogenesis of capillary endothelium through the arrest of endothelial cell proliferation and migration at the arterial-venous interface.
Similar articles
-
Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.Mol Cell Biol. 2001 Nov;21(21):7429-41. doi: 10.1128/MCB.21.21.7429-7441.2001. Mol Cell Biol. 2001. PMID: 11585923 Free PMC article.
-
Heterogeneity of the signal transduction pathways for VEGF-induced MAPKs activation in human vascular endothelial cells.J Cell Physiol. 2001 Aug;188(2):201-10. doi: 10.1002/jcp.1107. J Cell Physiol. 2001. PMID: 11424087
-
Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.Nat Cell Biol. 2001 May;3(5):527-30. doi: 10.1038/35074604. Nat Cell Biol. 2001. PMID: 11331884
-
The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.Mol Biol Rep. 2020 Jun;47(6):4681-4690. doi: 10.1007/s11033-020-05470-y. Epub 2020 Jun 2. Mol Biol Rep. 2020. PMID: 32488576 Review.
-
Regulation of signaling interactions and receptor endocytosis in growing blood vessels.Cell Adh Migr. 2014;8(4):366-77. doi: 10.4161/19336918.2014.970010. Cell Adh Migr. 2014. PMID: 25482636 Free PMC article. Review.
Cited by
-
An EPHB4-RASA1 signaling complex inhibits shear stress-induced Ras-MAPK activation in lymphatic endothelial cells to promote the development of lymphatic vessel valves.bioRxiv [Preprint]. 2023 Nov 23:2023.11.22.568378. doi: 10.1101/2023.11.22.568378. bioRxiv. 2023. PMID: 38045382 Free PMC article. Preprint.
-
An optogenetic-phosphoproteomic study reveals dynamic Akt1 signaling profiles in endothelial cells.Nat Commun. 2023 Jun 26;14(1):3803. doi: 10.1038/s41467-023-39514-1. Nat Commun. 2023. PMID: 37365174 Free PMC article.
-
EPHB4-RASA1-Mediated Negative Regulation of Ras-MAPK Signaling in the Vasculature: Implications for the Treatment of EPHB4- and RASA1-Related Vascular Anomalies in Humans.Pharmaceuticals (Basel). 2023 Jan 23;16(2):165. doi: 10.3390/ph16020165. Pharmaceuticals (Basel). 2023. PMID: 37259315 Free PMC article. Review.
-
Cellular loci involved in the development of brain arteriovenous malformations.Front Hum Neurosci. 2022 Sep 21;16:968369. doi: 10.3389/fnhum.2022.968369. eCollection 2022. Front Hum Neurosci. 2022. PMID: 36211120 Free PMC article. Review.
-
Identification and validation of four photodynamic therapy related genes inhibiting MAPK and inducing cell cycle alteration in squamous cell carcinoma.Front Oncol. 2022 Aug 4;12:946493. doi: 10.3389/fonc.2022.946493. eCollection 2022. Front Oncol. 2022. PMID: 35992777 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
